Table 1.
Patient characteristics from the Gustave Roussy hospital discharge database for the year 2019.
| Cancer type | All patientsa (%) | New patients by cancer type (%b) | Metastatic patients by cancer type (%b) |
|---|---|---|---|
| Acute leukaemia | 118 (2.0) | 23 (19.5) | NA |
| Bladder | 64 (1.1) | 5 (7.8) | 36 (56.3) |
| Breast | 1906 (32.0) | 817 (42.9) | 190 (10.0) |
| Cervix | 256 (4.3) | 24 (9.4) | 22 (8.6) |
| Colon | 185 (3.1) | 43 (23.2) | 91 (49.2) |
| Gastroesophageal | 58 (1.0) | 16 (27.6) | 27 (46.6) |
| Germinal seminoma | 61 (1.0) | 2 (3.3) | 33 (54.1) |
| Head and neck | 452 (7.6) | 183 (40.5) | 44 (9.7) |
| Kidney | 46 (0.8) | 8 (17.4) | 46 (100) |
| Liver | 30 (0.5) | 8 (26.7) | 10 (33.3) |
| Lung | 426 (7.2) | 122 (28.6) | 227 (53.3) |
| Lymphoma | 189 (3.2) | 46 (24.3) | NA |
| Myeloma | 87 (1.5) | 38 (43.7) | NA |
| Neuroendocrine tumours | 46 (0.8) | 19 (41.3) | NA |
| Ovary | 143 (2.4) | 52 (36.4) | 87 (60.8) |
| Pancreas | 41 (0.7) | 9 (22.0) | 20 (48.8) |
| Prostate | 390 (6.5) | 63 (16.2) | 85 (21.8) |
| Sarcomas | 268 (4.5) | 74 (27.6) | 62 (23.1) |
| Melanoma | 585 (9.8) | 146 (25.0) | 102 (17.4) |
| Thyroid | 376 (6.3) | 158 (42.0) | 77 (20.5) |
| Endometrium | 237 (4.0) | 33 (13.9) | 45 (19.0) |
| ALL | 5964 (100.0) | 1889 (31.7) | 1204 (20.2) |
NA: not applicable.
a
In this table, only patients under active treatment using hospital resources (surgery blocks, beds in the postsurgery unit, chemotherapy sessions, radiotherapy sessions, beds for haematopoietic stem cell transplant) considered in the study are taken into account. Percentages are calculated with respect to the total number of patients.
b
Percentages are calculated with respect to all patients within each cancer type.